ACOG
Alpha Cognition Inc.
Key Financials
Revenue
$10.2M
↓ 89.8%
Net Income
$-20669875
↓ 41.2%
Operating Income
$-22660689
↓ 91.1%
EPS (Diluted)
$-1.18
↑ 41.6%
Cash & Equivalents
$66.0M
↑ 36.0%
Shareholders' Equity
$62.5M
↑ 50.8%
Total Assets
$79.7M
↑ 57.1%
Total Liabilities
$17.2M
↑ 85.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/17/2026 | View on SEC |
| 3 | 4/17/2026 | View on SEC |
| 8-K | 4/14/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 4 | 3/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACOG |
| Company Name | Alpha Cognition Inc. |
| CIK | 1655923 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | (858) 344-4375 |